register

Marketing & Strategy

Edwards Lifesciences award-winning PR campaign highlights the complexities to ‘big, bold advancements’: PRIME Awards 2022

Health Industry Hub | December 7, 2022 |

Marketing & Strategy: In recognising and celebrating excellence in healthcare marketing and communications in the pharmaceutical and life science industry, Health Industry Hub was the proud media partner for the PRIME Awards again this year.

Edwards Lifesciences was crowned the winner of the Best PR Campaign – Awareness and Advocacy. In an interview with Health Industry Hub, Pat Williams, Vice President of Edwards Lifesciences ANZ & Korea, reflected on the unmet clinical need behind the award-winning campaign that was led by VIVA! Communications, and shared the components that made the campaign such a success.

Pat discussed the benefits of engaging multiple stakeholders to drive improvements in access and the role of media, in its diverse forms, to drive policy changes in improving equitable and timely access to novel technologies.

He commented on the Zimmerman Review and subsequent report and the advancements he would you like to see to the complex regulatory and reimbursement landscape in Australia in improving better patient care and outcomes.

Pat stated “Our regulatory and reimbursement landscapes are antiquité. That’s it, period. They’re outdated. But it was interesting during COVID how things moved quickly when it had to be. Our ‘COVID’ is every day. We have patients that have numerous structural heart diseases and problems, which we can fix.

“What’s missing in this report is what industry, clinicians, researchers and patient groups want to see as to how we can make the reg and the reimbursement landscape approve these novel medical devices say in 200 days rather than 1300 days.”

He added “I would like to see the Albanese Government re-engage with the folks that were involved in this inquiry and take on some of the recommendations that were in the report.”

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Medtronic partners with local researchers in stroke trial

Medtronic partners with local researchers in stroke trial

Health Industry Hub | March 1, 2024 |

MedTech & Diagnostics News: Endovascular thrombectomy has been shown to be more effective in reducing disability than medical therapy alone […]

More


News & Trends - Pharmaceuticals

Health Ministers reflect on the reforms and complexities facing the healthcare system

Health Ministers reflect on the reforms and complexities facing the healthcare system

Health Industry Hub | March 1, 2024 |

Pharma News: Mark Butler MP, Federal Minister for Health, and Senator Anne Ruston, Shadow Minister for Health, reflected on the […]

More


News & Trends - Pharmaceuticals

Gilead seeks funding of CAR T-cell therapy in follicular lymphoma

Gilead seeks funding of CAR T-cell therapy in follicular lymphoma

Health Industry Hub | March 1, 2024 |

Pharma News: Gilead has applied to the Medical Services Advisory Committee (MSAC) for funding of its cutting-edge CAR T-cell therapy, […]

More


News & Trends - MedTech & Diagnostics

Should private insurers face scrutiny for soaring profits while patients foot the bill? MTAA, Private Healthcare Australia

Should private health insurers face scrutiny for soaring profits while patients foot the bill?

Health Industry Hub | March 1, 2024 |

MedTech & Diagnostics News: In a clash of interests, the Medical Technology Association of Australia (MTAA) has once again urged […]

More


This content is copyright protected. Please subscribe to gain access.